According to GlycoMimetics 's latest financial reports and stock price the company's current number of shares outstanding is 64,349,709. At the end of 2023 the company had 64,349,709 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 64.34 M | 21.5% |
2022 | 52.96 M | 1.83% |
2021 | 52.01 M | 8.37% |
2020 | 47.99 M | 10.66% |
2019 | 43.37 M | 0.53% |
2018 | 43.14 M | 31.84% |
2017 | 32.72 M | 41.6% |
2016 | 23.11 M | 21.36% |
2015 | 19.04 M | 0.74% |
2014 | 18.9 M | 1224.22% |
2013 | 1.42 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 3,640.81% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 8,675.49% | ๐บ๐ธ USA |
Sanofi SNY | 2,507,200,000 | 3,796.21% | ๐ซ๐ท France |
Palatin Technologies PTN | 14,097,757 | -78.09% | ๐บ๐ธ USA |
bluebird bio
BLUE | 109,098,000 | 69.54% | ๐บ๐ธ USA |